Catheters Market Size, Share & Forecast 2026-2033

Overview

The Global Catheters Market size was valued at USD 32.8 billion in 2025 and is expected to reach USD 65 billion by 2033, growing with a CAGR of 8.9% during the forecast period 2026-2033. The rising prevalence of cardiovascular diseases (CVDs) is a significant factor driving growth in the global catheters market, as the increasing burden of heart and vascular disorders continues to expand the demand for diagnostic and minimally invasive interventional procedures.

According to projections based on the Global Burden of Disease (GBD) 2019 study, cardiovascular disease prevalence is expected to increase by 90.0% between 2025 and 2050, while crude mortality is projected to rise by 73.4% and crude disability-adjusted life years (DALYs) by 54.7%. Annual cardiovascular deaths are forecast to reach approximately 35.6 million by 2050, up from 20.5 million in 2025. This growing patient population is driving higher volumes of procedures such as coronary angiography, angioplasty, cardiac electrophysiology, and structural heart interventions, all of which depend on a wide range of specialized catheters for diagnosis, treatment, and patient management.

The increasing clinical demand is also accelerating innovation in interventional devices, with manufacturers introducing next-generation catheter systems that improve navigation, precision, and procedural outcomes. For example, in February 2024, CERENOVUS, Inc., a division of Johnson & Johnson MedTech, launched the CEREGLIDE™ 71 Intermediate Catheter featuring TruCourse™ technology for the revascularization of patients with acute ischemic stroke.

Such product advancements reflect the industry's focus on addressing the growing burden of cardiovascular and neurovascular diseases through enhanced catheter performance and interventional treatment options. As the incidence of cardiovascular conditions continues to rise globally, the combination of increasing procedure volumes and continuous technological innovation is expected to sustain robust demand for cardiovascular catheters, supporting long-term growth of the global catheters market.

Drivers

Growing Push for  Antimicrobial Catheters

Antimicrobial catheters are emerging as a key growth driver in the global catheters market, as healthcare providers increasingly prioritize infection prevention and improved patient outcomes, particularly in hospital settings where catheter-associated infections remain a major concern. These specialized catheters are designed to reduce bacterial colonization through advanced antimicrobial coatings, lowering the risk of catheter-associated urinary tract infections (CAUTIs) and other device-related infections, supporting their growing adoption across acute and long-term care facilities.

This trend is reinforced by ongoing clinical research demonstrating their effectiveness. For instance, in February 2026, a published multicenter randomized controlled trial titled "Antimicrobial catheters coated with poly-L-lysine for the prevention of bacteriuria in adults requiring short-term catheterization" evaluated 300 adults requiring short-term catheterization and found that poly-L-lysine (PLL)-coated urinary catheters were noninferior to noble metal alloy (NMA)-coated catheters in preventing catheter-associated bacteriuria (6.9% vs. 10.1%).

The study also reported a lower proportion of patients with abnormal urine white blood cell counts and a comparable safety profile, highlighting the potential of next-generation antimicrobial coatings to improve clinical outcomes. As hospitals continue to emphasize infection control, reduce healthcare-associated complications, and enhance patient safety, demand for advanced antimicrobial catheters is expected to increase, contributing significantly to the expansion of the global catheters market.

Increasing Demand for Minimally Invasive Procedures

The increasing demand for minimally invasive procedures is a key factor driving growth in the global catheters market, as these procedures offer advantages such as reduced surgical trauma, lower complication rates, shorter hospital stays, and faster patient recovery compared with traditional open surgeries.

Catheters play a critical role in minimally invasive interventions across cardiovascular, neurovascular, urological, and peripheral vascular applications, creating sustained demand for devices that provide superior flexibility, trackability, and navigation in complex anatomies. In September 2025, Terumo Neuro presented real-world physician preference data at the 17th Annual European Society of Minimally Invasive Neurological Therapy (ESMINT) Congress for its SOFIA™ Flow 88 Aspiration Catheter, based on 70 stroke procedures performed across 16 hospitals in the EMEA region.

The study showed that 83% of physicians reported the catheter reliably reached target locations even in anatomically challenging cases, 100% rated it as the same or better than the SOFIA™ Plus 6F for trackability, and 92% rated its overall performance as the same, better, or much better than alternative aspiration catheters. These findings highlight the growing emphasis on next-generation catheter platforms that improve procedural efficiency and physician confidence, supporting the expanding adoption of catheter-based therapies and driving continued growth of the global catheters market.

Restraint

Product Recalls

Product recalls are a significant restraint on the global catheters market because they disrupt product availability, increase regulatory scrutiny, raise healthcare providers' concerns about device reliability, and impose substantial financial and reputational costs on manufacturers. Recalls can also delay clinical procedures, reduce physician confidence in affected product lines, and increase the need for additional quality assurance and compliance measures, ultimately slowing market growth.

For example, in April 2025, BD recalled its PowerPICC Catheters after identifying tubing that exceeded melt flow index specifications, leading to material fatigue, leaks, and potential catheter fractures, affecting more than 183,000 devices in the United States. Similarly, in June 2025, Cook Medical recalled its Beacon Tip Catheters following reports that the catheter tip could separate during use, creating serious risks such as sepsis and vessel perforation.

These incidents underscore the critical importance of manufacturing quality, material integrity, and rigorous post-market surveillance in the catheter industry, while highlighting how product recalls can negatively impact market expansion by increasing regulatory oversight, elevating product development costs, and reducing customer trust.

Product recalls may also interrupt hospital procurement cycles, delay clinical adoption of new devices, increase inventory replacement costs, and strengthen regulatory oversight, creating additional challenges for manufacturers seeking commercial expansion.

Catheters Market Trends & Opportunities

Integration of Artificial Intelligence

The integration of artificial intelligence (AI) is emerging as a significant trend in the catheters market, driving the development of next-generation catheter designs that improve clinical performance, reduce complications, and enhance patient outcomes. Rather than being limited to imaging and procedural guidance, AI is increasingly being applied to catheter design optimization, enabling researchers to create devices with superior functional characteristics.

For example, in January 2024, a Caltech study titled "AI-aided geometric design of anti-infection catheters" introduced a novel catheter featuring AI-optimized, fin-like triangular protrusions on its inner surface that disrupt bacteria's ability to swim upstream, thereby reducing the risk of catheter-associated urinary tract infections (CAUTIs).

Laboratory experiments demonstrated that the AI-designed geometry reduced upstream bacterial movement by approximately 100-fold without relying on antibiotics or antimicrobial coatings, highlighting a promising non-chemical approach to infection prevention. Such advancements underscore how AI is accelerating innovation in catheter technology by enabling data-driven device design, improving infection control, and supporting the development of safer, more effective catheters, thereby contributing to the long-term growth and evolution of the global catheters market.

Material Innovation

Material innovation is emerging as a prominent trend in the global catheters market, with manufacturers increasingly investing in biocompatible materials, hydrophilic coatings, nitinol technologies, and advanced biomaterials that enhance catheter flexibility, durability, kink resistance, biocompatibility, and overall procedural performance. Among these materials, nitinol has gained significant importance due to its unique shape-memory and superelastic properties, which enable improved navigation through complex vascular anatomies while reducing the risk of vessel trauma.

To support the growing demand for high-performance catheter materials, companies are expanding manufacturing capabilities and strengthening supply chains. In May 2026, Confluent Medical Technologies announced the opening of its 26,000-square-foot Nitinol Wire Center of Excellence in Hyderabad, India, doubling the company's nitinol wire production capacity.

The ISO 13485-compliant facility provides dedicated manufacturing for nitinol wire with lead times as short as four weeks and ultra-tight tolerances of up to ±0.0002 inches, reinforcing a vertically integrated supply chain developed over more than three decades. Such investments in advanced material manufacturing are enabling medical device manufacturers to develop next-generation catheters with enhanced mechanical properties, improved reliability, and greater precision, supporting continued innovation and growth across the global catheters market.

Segment Analysis

The global catheters market report is segmented based on type, indication, end user and region.

Expanding Clinical Applications of Cardiovascular Catheters

The cardiovascular catheter market segment held the largest share of the global catheters market, accounting for 29% in 2025, due to the rising prevalence of cardiovascular diseases, increasing adoption of image-guided cardiac interventions, and continuous advancements in catheter-based diagnostic and therapeutic technologies.

The growing burden of coronary artery disease, arrhythmias, and other cardiovascular conditions is driving demand for procedures such as coronary angiography, electrophysiology procedures, cardiac ablation, and intravascular imaging, which rely on angiography catheters, guiding catheters, coronary balloon catheters, and IVUS/OCT catheters. In addition, healthcare providers are increasingly adopting advanced catheter solutions to improve procedural accuracy, reduce recovery time, and enhance patient outcomes.

Technological innovation and strategic industry developments are further strengthening the segment’s growth; for instance, in April 2026, Medtronic completed the acquisition of CathWorks to enhance its coronary diagnostics portfolio and advance the future of cardiovascular care. Such investments in next-generation diagnostic and interventional solutions are expected to expand clinical applications of cardiovascular catheters, supporting the segment’s continued dominance in the global catheters market.

Increasing Adoption of Innovative Urological Catheter Solutions

The urological catheter market segment held a significant share of the global catheters market due to the high prevalence of urinary disorders, increasing aging population, rising number of urological procedures, and widespread use of urinary catheterization in hospitals, long-term care facilities, and home healthcare settings.

Conditions such as urinary retention, urinary incontinence, benign prostatic hyperplasia, neurogenic bladder, and postoperative bladder management require effective catheter-based solutions, driving consistent demand for Foley catheters, intermittent catheters, external urinary catheters, and advanced urinary catheter solutions. The growing focus on reducing catheter-associated urinary tract infections (CAUTIs) and improving patient comfort has also accelerated the adoption of advanced urological catheters with antimicrobial coatings, improved materials, and enhanced designs.

In April 2025, Silq Technologies Corporation secured a national group purchasing agreement and received the Technology Breakthrough Designation from Premier, Inc., enabling Premier members to access pre-negotiated pricing and terms for ClearTract catheters. Such strategic partnerships and advancements in catheter technology are improving product accessibility and supporting broader adoption of innovative urological catheter solutions, contributing to the segment’s strong position in the global catheters market.

Continued Innovation in Specialty Catheter Platforms is Driving Adoption

The specialty catheters market segment is growing in the global catheters market due to the increasing demand for advanced, procedure-specific devices designed to treat complex cardiovascular, peripheral vascular, neurovascular, and other specialized conditions. Rising prevalence of peripheral artery disease, structural heart disorders, and other chronic diseases is driving the adoption of specialty catheters that offer improved drug delivery, precision, and therapeutic outcomes compared with conventional catheter systems.

In addition, advancements in catheter technologies, including drug-coated balloons, ablation catheters, and advanced imaging catheters, are expanding applications of specialty devices in complex endovascular procedures. In April 2025, Surmodics, Inc. announced the publication of the TRANSCEND clinical trial, a global randomized study demonstrating that the SurVeil™ drug-coated balloon (DCB) was non-inferior to the IN.PACT™ Admiral™ DCB for safety and efficacy in patients with femoropopliteal arterial disease while using a substantially lower drug dose.

 The study, involving 446 patients across 65 sites in nine countries, showed comparable 12-month primary patency and safety outcomes between the two devices, supporting the effectiveness of advanced low-dose drug delivery technology. Such clinical evidence and continued innovation in specialty catheter platforms are increasing physician adoption, improving treatment options for complex conditions, and supporting broader adoption across multiple interventional specialties worldwide.

Growing Need for Rapid and Effective Treatment of Ischemic Stroke is Driving Demand for Specialized Neurovascular Catheters

The neurovascular conditions segment is the fastest-growing segment in the global catheters market due to the increasing prevalence of stroke and other neurovascular disorders, rising adoption of minimally invasive endovascular procedures, and continuous advancements in catheter technologies. The growing need for rapid and effective treatment of ischemic stroke is driving demand for specialized neurovascular catheters used in mechanical thrombectomy and other interventions, as these devices enable improved vessel access, precise navigation, and faster clot removal.

Technological innovations that enhance catheter flexibility, stability, and durability are further accelerating market growth. In January 2025, Radical Catheter Technologies announced that its 8F Neurovascular Catheter received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The catheter is based on the company’s patented ribbon technology platform and features an enlarged inner diameter designed to expand therapeutic options in neurovascular procedures while providing enhanced flexibility, stability, and durability.

Such advancements are improving procedural efficiency, expanding treatment possibilities for complex neurovascular conditions, and supporting the rapid growth of the neurovascular catheter market segment within the global catheters market.

Geographical Penetration

North America Catheters Market: Driven by High Prevalence of Chronic Diseases & Advanced Healthcare Infrastructure

North America held the largest share of the global catheters market, accounting for 43% in 2025, driven by the high prevalence of chronic diseases, advanced healthcare infrastructure, strong adoption of catheter-based interventions, and continuous innovation in catheter technologies.

The region’s significant burden of cardiovascular diseases is a major contributor to market growth, with more than 184 million people, representing over 61% of the U.S. population, projected to have some form of cardiovascular disease (CVD), while total CVD-related costs in the U.S. are expected to increase to $1.8 trillion by 2050, according to American Heart Association.

This rising disease burden is increasing demand for cardiovascular, neurovascular, and other specialized catheters used in diagnosis and treatment procedures. In addition, favorable reimbursement systems, high healthcare expenditure, and the presence of leading medical device manufacturers are supporting widespread adoption of catheter-based vascular interventions.

Technological advancements are further strengthening the regional market, as demonstrated in January 2025 when Dr. Bruce Gardner, a radiologist at Sanford Health, received U.S. FDA approval for an innovative catheter design aimed at preventing accidental dislodgement injuries. The catheter features a mechanism that enables rapid deflation of the retention balloon when excessive tension is applied, helping reduce potential patient harm. Such developments, combined with increasing demand for safer and more effective interventional solutions, are expected to maintain North America’s leading position in the global catheters market.

Europe Catheters Market : Driven by Growing Focus on Infection Prevention

The catheters market in Europe is growing due to the rising prevalence of chronic diseases, increasing demand for catheter-based interventions, growing focus on infection prevention, and continuous advancements in catheter-based technologies. The region faces a significant healthcare burden from antimicrobial resistance (AMR), with the European Commission reporting that AMR is responsible for more than 35,000 deaths annually, increasing the need for advanced catheter solutions that help reduce infection risks and improve patient outcomes.

In addition, the rising incidence of cardiovascular conditions, particularly peripheral artery disease (PAD), is driving demand for specialized cardiovascular and vascular catheters. More than 15 million people aged 45 and older in Europe are estimated to suffer from PAD, creating a substantial need for innovative catheter-based interventions to improve blood flow and reduce complications such as limb ischemia and amputation.

Technological innovation is further supporting market expansion; for example, in September 2025, Johnson & Johnson launched the Shockwave Javelin Peripheral IVL Catheter in Europe, a novel intravascular lithotripsy (IVL) platform designed to modify calcium in severely narrowed vessels and expand treatment options for patients with complex PAD. The device’s Forward IVL platform, featuring a lithotripsy emitter positioned directly behind the catheter tip, is designed to address challenging calcified lesions that are difficult to cross with conventional devices.

Such advancements, combined with increasing healthcare investment, expanding reimbursement support, and continued hospital modernization, are accelerating the adoption of catheter-based cardiovascular interventions across Europe.

Asia-Pacific Catheters Market: Driven by Rising Demand for Minimally Invasive Treatments

The Asia-Pacific region is the fastest-growing region in the global catheters market due to the rising prevalence of chronic diseases, increasing healthcare expenditure, improving medical infrastructure, and growing adoption of catheter-based interventions. The region is experiencing a significant burden of renal and cardiovascular disorders, creating strong demand for specialized cardiovascular, urinary, dialysis, and vascular access catheters and other specialized catheter technologies.

According to National Kidney Foundation, Asian populations are reported to be 1.4 times more likely than White populations to experience kidney failure, and the number of patients with end-stage kidney disease (ESKD) in the region is projected to exceed 1 million by 2030, driving the need for urinary, dialysis, and other catheter technologies. In addition, the growing incidence of cardiovascular diseases and the expansion of electrophysiology and interventional cardiology procedures are accelerating demand for advanced cardiac catheters.

Technological innovation and local regulatory approvals are further supporting market growth; for example, in November 2025, MicroPort® EP (Shanghai MicroPort EP MedTech Co., Ltd.) received approval from China’s National Medical Products Administration (NMPA) for the PulseMagic™ TrueForce® single-use pressure-sensing pulsed field ablation (PFA) catheter. The device, designed with real-time pressure sensing, saline irrigation, and integration with the Columbus® 3D cardiac mapping system, enhances precision and consistency in non-thermal cardiac ablation procedures.

Such advancements, combined with the region’s growing patient population, increasing access to specialized interventional technologies, and rising demand for minimally invasive treatments, are expected to make Asia-Pacific the fastest-growing market for catheters globally.

South America Catheters Market: Driven by Increasing Prevalence of Chronic Diseases

The catheters market in South America is growing due to the increasing prevalence of chronic diseases, rising demand for minimally invasive procedures, improving healthcare infrastructure, and greater access to catheter-based diagnostic and therapeutic technologies. The region is experiencing a growing burden of cardiovascular diseases, diabetes, kidney disorders, and urological conditions, which is increasing the need for diagnostic and therapeutic catheter-based procedures across hospitals and specialty care centers.

The expanding aging population and rising number of patients requiring long-term care are also contributing to higher adoption of urinary, cardiovascular, and dialysis catheters. Additionally, healthcare systems across countries such as Brazil, Argentina, and Chile are investing in modernizing medical facilities and improving access to advanced interventions, supporting the use of catheter-based treatments for complex conditions.

Middle East & Africa Catheters Market: Driven by Strategic Collaborations

The catheters market in the Middle East & Africa is growing due to the rising burden of cardiovascular diseases, increasing healthcare investments, improving access to catheter-based interventional technologies, and the expansion of catheter-based interventional procedures. Cardiovascular conditions represent a major healthcare challenge in the region, creating significant demand for diagnostic and therapeutic catheter-based solutions such as balloon catheters, cardiac imaging catheters, and catheterization laboratory technologies.

In the Middle East and North Africa, more than 1.4 million people die from cardiovascular diseases annually, while Africa reports more than 1 million cardiovascular disease-related deaths each year, highlighting the urgent need for advanced cardiac care solutions. Healthcare providers are increasingly adopting catheter-based interventions to improve diagnosis, treatment precision, and patient outcomes, supported by government initiatives to modernize healthcare infrastructure and expand access to specialized medical services.

Strategic collaborations and technology launches are further accelerating the adoption of catheter technologies across the region. In February 2026, FUJIFILM Middle East FZE launched its Interventional Cardiology Business Line in the Middle East and Africa in collaboration with Innvolution Healthcare to expand access to advanced cardiovascular care solutions. The portfolio includes cardiac catheterization laboratories, angiography systems, Optical Coherence Tomography (OCT) systems, balloon catheters, drug-eluting stents, and other interventional cardiac accessories designed to support precision diagnosis and personalized treatment.

The introduction of these advanced solutions is helping healthcare facilities address the growing demand for catheter-based cardiovascular procedures while improving clinical capabilities. As cardiovascular disease prevalence continues to rise and investments in healthcare technology increase, the Middle East & Africa region is expected to witness sustained growth in the catheters market.

Key Developments

·         In April 2026, Wellspect HealthCare launched the Surity™ Male External Catheter, a non-invasive solution for men living with urinary incontinence. This builds on the company's expanding portfolio of reliable urinary incontinence management solutions in the U.S., following the introduction of the Surity™ Female External Catheter earlier this year, and ahead of the anticipated launch of the Surity™ Urinary Management System.

·         In June 2026, Access Vascular Inc (AVI) and Medline have announced a multi-year agreement to accelerate the rollout of AVI’s next-generation catheters, HydroMID and HydroPICC, which recently received an anti-thrombogenic indication from the US Food and Drug Administration (FDA).

·         In July 2026, Johnson & Johnson received U.S. FDA approval for the Dual Energy ThermoCool SmartTouch SF Platform (DE STSF), an integrated catheter ablation solution that enables electrophysiologists to deliver both radiofrequency (RF) and pulsed field (PF) energy through a single catheter.